Immune inactivation by neuropilin-1 predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer
Yanze Yu, Han Zeng, Kaifeng Jin, Runze You, Zhaopei Liu, Hongyi Zhang, Chunnan Liu, Xiaohe Su, Sen Yan, Yuan Chang, Li Liu, Le Xu, Jiejie Xu, Yu Zhu, Zewei Wang
Topics & Concepts
MedicineBlockadeOncologyImmunotherapyBladder cancerImmune checkpointImmune systemNeuropilin 1AdjuvantInternal medicineImmunologyCancerCancer researchReceptorVEGF receptorsVascular endothelial growth factorBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and BiomarkersAngiogenesis and VEGF in Cancer